MedTrace Logo

A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis

NCT01085760 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2013-09-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Vancomycin or Metronidazole is safe and beneficial in the treatment of Primary Sclerosing Cholangitis.

Conditions

  • Primary Sclerosing Cholangitis

Interventions

DRUG

Vancomycin

Comparison of different doses of drug

DRUG

Vancomycin

Comparison of different doses of drug

DRUG

Metronidazole

Comparison of different doses of drug

DRUG

Metronidazole

Comparison of different doses of drug

DRUG

Vancomycin

Comparison of different drug doses

Sponsors & Collaborators

  • PSC Partners Seeking a Cure

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Jayant A Talwalkar, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01085760 on ClinicalTrials.gov